comparemela.com

StockNews.com upgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a hold rating to a buy rating in a report published on Tuesday. A number of other equities research analysts have also commented on PRTK. BTIG Research reduced their price target on Paratek Pharmaceuticals from $24.00 to $5.00 in a research report on Tuesday, […]

Related Keywords

Jamesd Dondero , , Ci Private Wealth , Paratek Pharmaceuticals Company Profile , Paratek Pharmaceuticals , Commonwealth Equity Services , Paratek Pharmaceuticals Inc , News Ratings For Paratek Pharmaceuticals Daily , Cutter Co Brokerage Inc , Paratek Pharmaceuticals Price Performance , Securities Exchange Commission , Get Rating , Exchange Commission , Equity Services , Exoduspoint Capital Management , Paratek Pharmaceuticals Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.